Major adverse cardiovascular events in patients treated with oral Janus kinase inhibitors for atopic dermatitis: a systematic review and meta-analysis

CONCLUSION: Our review highlighted rare cases of MACE among JAK inhibitors users for AD. Janus kinase inhibitors may have little to no effect on the occurrence of MACEs in patients with AD compared to comparators but the evidence is very uncertain. Real-life, long-term, population-level safety studies are needed.PMID:37410552 | DOI:10.1093/bjd/ljad229

Source: The British Journal of Dermatology - July 6, 2023 Category: Dermatology Authors: C écile Ertus Lucie-Marie Scailteux Alain Lescoat Pauline Berthe Vincent Auffret Alain Dupuy Emmanuel Oger Catherine Droitcourt Source Type: research